The content on this page is designed for Australia. Check courses designed for Canada (EN)

This course has expired. View available courses.

Endocrinology, Medication Management

DPP-4 inhibitors for Type 2 Diabetes. Who, when, and why?

Medical treatment of Type 2 Diabetes (T2D) has become increasingly complex, as new classes of hypoglycaemic medications are developed and clinical guidelines are updated to reflect these developments.

DPP4is are a useful addition to many T2D treatment plans, especially for complex patients with comorbidities that limit the use of other drug classes.

Upon completion of this program, you will be able to confidently identify patient groups likely to benefit from DPP4is, and have the knowledge to appropriately prescribe DPP4is.


This program was developed by MDBriefcase, and funding provided by Boehringer Ingelheim.

DURATION

1 hr

PROFESSION

Physician

# OF CREDITS

2

ACCREDITATION

ADEA, RACGP CPD Program

EXPIRY DATE

2022-12-31

Medical treatment of Type 2 Diabetes (T2D) has become increasingly complex, as new classes of hypoglycaemic medications are developed and clinical guidelines are updated to reflect these developments.

DPP4is are a useful addition to many T2D treatment plans, especially for complex patients with comorbidities that limit the use of other drug classes.

Upon completion of this program, you will be able to confidently identify patient groups likely to benefit from DPP4is, and have the knowledge to appropriately prescribe DPP4is.


This program was developed by MDBriefcase, and funding provided by Boehringer Ingelheim.

Faculty

Anita Sharma, General Practitioner, Queensland (QLD)

Tom Dover, Endocrinologist, Queensland (QLD)

Learning objectives

Upon completion of this continuing education program participants will be better able to:

  • Review the use of DPP4is for patients with T2D in line with current guidelines
  • Identify patients for whom DPP4is are indicated and a good option from a clinical, practical and treatment goal perspective.
  • Determine when a DPP4i is an appropriate option as dual therapy or subsequent medication to reach individualised diabetes treatment goals.
  • Overcome clinician-mediated and patient-mediated clinical inertia to initiate timely escalation of diabetes treatment, with the aim of reaching glycaemic targets, improving medication adherence and considering patients’ preferences.
  • Confidently discuss with patients a DPP4i option, including counselling on the advantages and disadvantages of changing their medication in order to achieve a better clinical outcome.

Accreditation

This Active Learning Module has been approved by RACGP CPD Program for 2 CPD points.

Activity no. 300955

Members are able to claim CPD activity points for 2 points through 'Quick log' on their RACGP CPD Dashboard.

This course is endorsed and accredited by the ADEA for 1 CPD point.

Cost of course:  
Free
# of credits: 2
Duration: 1 hr

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.